To understand the factors contributing to the synthesis of human apolipoprotein AI (apoAI), relative apoAI synthesis was measured from endoscopic biopsy samples obtained from 18 healthy volunteers. The relative amount of apoAI synthesis was directly correlated with steady state intestinal apoAI mRNA levels and a 10-fold within-group variability was observed. Analysis of genomic DNA from the subjects revealed five polymorphic sites which defined two haplotypes in the intestinal enhancer region of the apoAI gene located upstream of the apolipoprotein CIII gene transcriptional start site (+ 1): (-641 C to A, -630 G to A, -625 T to deletion, -482 C to T, and -455 T to C). The population frequencies of the wild-type and mutant alleles were 0.53 and 0.44, respectively. Mean steady state apoAI mRNA levels and mean relative apoAI synthesis were 49 and 37% lower, respectively, in homozygotes for the mutant allele and 28 and 41% lower, respectively, in heterozygotes than in homozygotes for the wild-type allele (P < 0.05 for both). Site-directed mutants of apoAI gene promoter/reporter constructs containing the above mutations were transfected into Caco-2 cells and showed a 46% decrease in transcriptional activity compared with the wild type (P < 0.001); however, no significant differences were observed in HepG2 cells. Electrophoretic mobility shift assays showed that the mutated sequences from -655 to -610 bound Caco-2 cell nuclear protein(s) while the wild type did not. These results indicate that intestinal apoAI gene transcription and protein synthesis are genetically determined and are reduced in the presence of common mutations which induced binding of nuclear protein(s), possibly a transcriptional repressor.
S Naganawa, H N Ginsberg, R M Glickman, G S Ginsburg
Title and authors | Publication | Year |
---|---|---|
Elevated interleukin-10: A new cause of dyslipidemia leading to severe HDL deficiency
AG Moraitis, LA Freeman, RD Shamburek, R Wesley, W Wilson, CM Grant, S Price, S Demosky, SG Thacker, A Zarzour, RL Hornung, F Pucino, G Csako, C Yarboro, IB McInnes, T Kuroiwa, D Boumpas, VK Rao, GG Illei, AT Remaley |
Journal of Clinical Lipidology | 2015 |
Elevated interleukin-10: A new cause of dyslipidemia leading to severe HDL deficiency
AG Moraitis, LA Freeman, RD Shamburek, R Wesley, W Wilson, CM Grant, S Price, S Demosky, SG Thacker, A Zarzour, RL Hornung, F Pucino, G Csako, C Yarboro, IB McInnes, T Kuroiwa, D Boumpas, VK Rao, GG Illei, AT Remaley |
Journal of Clinical Lipidology | 2014 |
Long-Range Regulatory Polymorphisms Affecting a GABA Receptor Constitute a Quantitative Trait Locus (QTL) for Social Behavior in Caenorhabditis elegans
A Bendesky, J Pitts, MV Rockman, WC Chen, MW Tan, L Kruglyak, CI Bargmann, M Hammarlund |
PLoS genetics | 2012 |
Genetics and molecular biology
J Pétremand, C Widmann |
Current Opinion in Lipidology | 2011 |
Apolipoprotein AI-CIII-AIV gene cluster polymorphisms in relation to cholesterol gallstone
YG YAO, X QIU, MK MA, DS PU, LJ XIAO |
Journal of Digestive Diseases | 2007 |
Association between the -455T>C promoter polymorphism of the APOC3gene and the metabolic syndrome in a multi-ethnic sample
RL Pollex, MR Ban, TK Young, P Bjerregaard, SS Anand, S Yusuf, B Zinman, SB Harris, AJ Hanley, PW Connelly, MW Huff, RA Hegele |
BMC Medical Genetics | 2007 |
Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral Therapy
AS Foulkes, DA Wohl, I Frank, E Puleo, S Restine, ML Wolfe, MP Dube, P Tebas, MP Reilly |
PLoS Medicine | 2006 |
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk
CQ Lai, LD Parnell, JM Ordovas |
Current Opinion in Lipidology | 2005 |
Low HDL Cholesterol Levels
MD Ashen, RS Blumenthal |
New England Journal of Medicine | 2005 |
Effect of glucosamine on apolipoprotein AI mRNA stabilization and expression in HepG2 cells
MJ Haas, NC Wong, AD Mooradian |
Metabolism | 2004 |
Abundant Raw Material for Cis-Regulatory Evolution in Humans
MV Rockman, GA Wray |
Molecular Biology and Evolution | 2002 |
Análisis de las regiones reguladoras de la expresión de apo A-I en sujetos con hipoalfalipoproteinemia
D Recalde, A Cenarro, AL García-Otín, T Tejedor, F Civeira, M Pocoví |
Clínica e Investigación en Arteriosclerosis | 2002 |
Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian-Indians
M Miller, J Rhyne, M Khatta, H Parekh, K Zeller |
The American Journal of Cardiology | 2001 |
Intestinal Lipid Metabolism
CM Mansbach, P Tso, A Kuksis |
2001 | |
Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin
GM Dallinga-Thie, M Groenendijk, RN Blom, TW Bruin, ED Kant |
Journal of lipid research | 2001 |
Novel genes for familial combined hyperlipidemia
BE Aouizerat, H Allayee, J Bodnar, KL Krass, L Peltonen, TW de Bruin, JI Rotter, AJ Lusis |
Current Opinion in Lipidology | 1999 |
A Bifunctional Regulatory Element of the Human ApoA-I Gene Responsive to a Distal Enhancer
DR Jones, M Leffak |
DNA and Cell Biology | 1999 |
Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
M Groenendijk, R, NH Blom, JI Rotter, TW de Bruin, GM Dallinga-Thie |
Journal of lipid research | 1999 |
The effect on transcription efficiency of the apolipoprotein AI gene of DNA variants at the 5′ untranslated region
XL Wang, RB Badenhop, AS Sim, DE Wilcken |
International Journal of Clinical & Laboratory Research | 1998 |
The Human CC Chemokine Receptor 5 (CCR5) Gene: MULTIPLE TRANSCRIPTS WITH 5′-END HETEROGENEITY, DUAL PROMOTER USAGE, AND EVIDENCE FOR POLYMORPHISMS WITHIN THE REGULATORY REGIONS AND NONCODING EXONS
S Mummidi, SS Ahuja, BL McDaniel, SK Ahuja |
The Journal of biological chemistry | 1997 |